Noom vs Wisp
Wisp costs $100 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
If you are choosing between Noom and Wisp, the first difference is cost: Wisp is $100 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Noom leads our six-part score, 6.7 to 6.5.
Noom vs Wisp price
Wisp is the cheaper way in: $99 a month against $199 a month at Noom. That is $100 less each month (50% lower), or about $1,200 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Noom ($199 a month vs $225 a month); tirzepatide is cheaper at Wisp ($99 a month vs $349 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format they match: each offers brand-name pens and compounded injections.
Where each one treats patients
Neither Noom nor Wisp publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
Noom
Wisp
Monthly subscription supplement, NOT a prescription GLP-1 medication. 'subscription' in form keeps it out of the GLP-1 hero price. drug omitted intentionally.
Zepbound $99/mo (compounded sublingual semaglutide $225/mo)
What each price covers
Noom's price also covers the clinician visit and coaching, which Wisp does not claim.
Wisp's price also covers the medication itself and shipping, which Noom does not claim.
Noom is silent on the medication itself, shipping and lab work.
Wisp is silent on the clinician visit, lab work and coaching.
That matters most for the drug: unless Noom confirms otherwise, budget for medication on top of its listed price.
Noom
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Wisp
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Noom scores 6.7 and Wisp 6.5 out of 10.
Noom is stronger on value (4.4 vs 3.5).
Wisp is stronger on support (4.5 vs 4.0).
Effectiveness, user experience, trust & safety and accessibility are within half a point.
Noom
6.7/10
Wisp
6.5/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Noom nor Wisp has an FDA warning letter on record with us.
Features & Coverage
| Feature | Noom | Wisp |
|---|---|---|
| Starting Price | $199/mo | ✓$99/mo |
| Features | 2 features | ✓8 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Noom
Noom is a behavioral weight loss app. It also prescribes GLP-1 medications through Noom Med.
Read our full Noom review →About Wisp
$225/month buys a compounded sublingual semaglutide drops formulation from Wisp. Its weight care vertical also stocks three brand names: Saxenda, Zepbound, and Wegovy. A board-certified provider completes the review inside 24-72 hours. LegitScript certification is in place.
Read our full Wisp review →Pros & Cons
Noom
What we like
- Semaglutide costs $199 a month, close to the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits and coaching
- We found no FDA warning letters issued to Noom
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Wisp
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication and shipping
- We found no FDA warning letters issued to Wisp
Watch-outs
- Semaglutide costs $225 a month, 22% above the $184 median for compounded semaglutide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Noom wins this one, 6.7 to 6.5, above all for coaching bundled into the price rather than sold separately. Wisp undercuts it by $100 a month, so if the monthly bill is what decides it, Wisp is the pick. Wisp fits better if an oral route if you will not self-inject is your priority.
Choose Noom if…
You want coaching bundled into the price rather than sold separately and an opening price near $199 a month.
Choose Wisp if…
You want an oral route if you will not self-inject and an opening price near $99 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Noom vs Wisp: FAQ
Close alternatives to Noom and Wisp
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.